NCT00004893 2016-07-19
Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
Clinical Trials
11 trialsNCT00003339 2014-05-22
Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma
University of Southern California
Phase 2 Completed
NCT00031733 2014-05-22
Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma
University of Southern California
Phase 2 Completed
NCT00015977 2014-03-07
Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
University of Chicago
Phase 2 Completed
NCT00026182 2013-08-26
Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003017 2013-06-21
Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003149 2013-06-21
Interleukin-12 in Treating Patients With Multiple Myeloma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00020449 2013-06-19
Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00026143 2013-06-05
Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003575 2013-02-08
Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00016289 2013-01-23
Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
National Cancer Institute (NCI)
Phase 2 Completed